Afm24 and atezolizumab combination in patients with advanced epidermal growth factor receptor-expressing (egfr(+)) solid tumors: initial results from the phase 1 doseescalation study
Regular and Young Investigator Award Abstracts（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined